Apotex Inc. v. Sanofi-Aventis, 2012 FC 553 (Ramipril*)
Justice Snider - 2012-05-23
Read full decision. Automatically generated summary:
Apotex Inc. (Apotex), the Plaintiff in this action, sells a generic version of ramipril – a drug used mainly to treat hypertension – into the Canadian market. Sanofi-Aventis Canada Inc. (Sanofi), one of the Defendants in this action, holds or has held patent rights to a brand-name version of ramipril – ALTACE.
Decision relates to:
- T-1357-09 - APOTEX INC. v. SCHERING CORPORATION ET AL
- A-191-12(2014 FCA 68) - which is an appeal from this decision